Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy. [electronic resource]
Producer: 20141121Description: 1955-64 p. digitalISSN:- 1557-3265
- Aged
- Carcinoma, Renal Cell -- drug therapy
- Exome
- Genome, Human
- Humans
- Indoles -- administration & dosage
- Male
- Middle Aged
- Neoplasm Metastasis
- Protein Kinase Inhibitors -- administration & dosage
- Pyrroles -- administration & dosage
- Signal Transduction -- genetics
- Sunitinib
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Tuberous Sclerosis Complex 1 Protein
- Tumor Suppressor Proteins -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.